Sun Yan, Yang Pan-Pan, Song Zhen-Yuan, Feng Yu, Hu Duan-Min, Hu Ji, Xu Guang-Yin, Zhang Hong-Hong
Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Department of Endocrinology, The East District of Suzhou Municipal Hospital, Suzhou, People's Republic of China.
J Pain Res. 2017 Jul 14;10:1645-1655. doi: 10.2147/JPR.S135017. eCollection 2017.
Patients with long-standing diabetes often demonstrate intestinal dysfunction, characterized as constipation or colonic hypersensitivity. Our previous studies have demonstrated the roles of voltage-gated sodium channels NaV1.7 and NaV1.8 in dorsal root ganglion (DRG) in colonic hypersensitivity of rats with diabetes. This study was designed to determine roles of antioxidant α-lipoic acid (ALA) on sodium channel activities and colonic hypersensitivity of rats with diabetes.
Streptozotocin was used to induce diabetes in adult female rats. Colonic sensitivity was measured by behavioral responses to colorectal distention in rats. The excitability and sodium channel currents of colon projection DRG neurons labeled with DiI were measured by whole-cell patch-clamp recordings. The expressions of NaV1.7 and NaV1.8 of colon DRGs were measured by western blot analysis.
ALA treatment significantly increased distention threshold in responding to colorectal distension in diabetic rats compared with normal saline treatment. ALA treatment also hyper-polarized the resting membrane potentials, depolarized action potential threshold, increased rheobase, and decreased frequency of action potentials evoked by ramp current stimulation. Furthermore, ALA treatment also reduced neuronal sodium current densities of DRG neurons innervating the colon from rats with diabetes. In addition, ALA treatment significantly downregulated NaV1.7 and NaV1.8 expression in colon DRGs from rats with diabetes.
Our results suggest that ALA plays an analgesic role, which was likely mediated by downregulation of NaV1.7 and NaV1.8 expressions and functions, thus providing experimental evidence for using ALA to treat colonic hypersensitivity in patients with diabetic visceral pain.
长期患糖尿病的患者常表现出肠道功能障碍,特征为便秘或结肠超敏反应。我们之前的研究已经证明了背根神经节(DRG)中的电压门控钠通道NaV1.7和NaV1.8在糖尿病大鼠结肠超敏反应中的作用。本研究旨在确定抗氧化剂α-硫辛酸(ALA)对糖尿病大鼠钠通道活性和结肠超敏反应的作用。
用链脲佐菌素诱导成年雌性大鼠患糖尿病。通过大鼠对结直肠扩张的行为反应来测量结肠敏感性。用全细胞膜片钳记录法测量用DiI标记的结肠投射DRG神经元的兴奋性和钠通道电流。通过蛋白质免疫印迹分析测量结肠DRG中NaV1.7和NaV1.8的表达。
与生理盐水处理相比,ALA处理显著提高了糖尿病大鼠对结直肠扩张反应的扩张阈值。ALA处理还使静息膜电位超极化,使动作电位阈值去极化,增加了基强度,并降低了斜坡电流刺激诱发的动作电位频率。此外,ALA处理还降低了糖尿病大鼠支配结肠的DRG神经元的神经元钠电流密度。另外,ALA处理显著下调了糖尿病大鼠结肠DRG中NaV1.7和NaV1.8的表达。
我们的结果表明,ALA发挥镇痛作用,这可能是通过下调NaV1.7和NaV1.8的表达及功能介导的,从而为使用ALA治疗糖尿病性内脏痛患者的结肠超敏反应提供了实验证据。